BioSystics, Inc., a recent spin-off from the University of Pittsburgh is seeking Series A financing to accelerate the path to patient digital twins for the pharmaceutical and healthcare industries. The BioSystics Analytics Platform™ (BioSystics-AP™) captures, analyzes, computationally models and shares … Read More
BioSystics Blog – Standard Sidebar
BioSystics is proud to be a Silver sponsor of the MPS World Summit being held in New Orleans, May 31 – June 3, 2022. At the meeting, we will be presenting the BioSystics Analytics platform, a platform for accessing, managing, … Read More
Funding from NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM)…
CEO Mark Schurdak announced that NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) has provided funding to implement an iPSC portal to promote sharing of iPSCs among the MPSCoRe COVID-19 consortium members. Access to the portal will … Read More
The MPS Database Center has jointly published a paper with the Tissuce Chip Validation Center at Texas A&M University (TAMU) that demonstrates the use of the MPS-Db for the analysis and reproducibility of the microphysiologyical systems. Sakolish C, Reese CE, … Read More
CEO Mark Schurdak announced that The National Center for Advancing Translational Sciences (NCATS) funding for the commercialization of the BioSystics Platform has been renewed through November 30, 2022.